Summary of the Standards, Options and Recommendations for the management of patients with nonmetastatic prostate cancer (2001).
Villers
A
A
CHRU Hôpital Huriez, Lille, France.
Pommier
P
P
Bataillard
A
A
Fervers
B
B
Bachaud
J M
JM
Berger
N
N
Bertrand
A F
AF
Bouvier
R
R
Brune
D
D
Daver
A
A
Fontaine
E
E
Haillot
O
O
Lagrange
J L
JL
Molinie
V
V
Muratet
J P
JP
Pabot du Chatelard
P
P
Peneau
M
M
Prapotnich
D
D
Ravery
V
V
Richaud
P
P
Rossi
D
D
Soulie
M
M
D000970:Antineoplastic Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003663:Decision Trees; D018450:Disease Progression; D006287:Health Planning Guidelines; D006801:Humans; D008017:Life Expectancy; D008297:Male; D009362:Neoplasm Metastasis; D011379:Prognosis; D011467:Prostate / Q000473:pathology*; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000097:blood / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D011878:Radiotherapy; D012015:Reference Standards; D012106:Research; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D017430:Prostate-Specific Antigen